Effect of exenatide, insulin and pioglitazone on bone metabolism in patients with newly diagnosed type 2 diabetes

Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: new advances

(2016) Meena Asmar et al.   Current Opinion in Endocrinology Diabetes and Obesity

Comparison of the effects on glycaemic control and β-cell function in newly diagnosed type 2 diabetes patients of treatment with exenatide, insulin or pioglitazone: a multicentre randomized parallel-group trial (the CONFIDENCE study)

(2014) W. Xu et al.   JOURNAL OF INTERNAL MEDICINE

Vitamin D deficiency, serum leptin and osteoprotegerin levels in older diabetic patients: an input to new research avenues

(2013) Stefania Maggi et al.   ACTA DIABETOLOGICA

Treatment of patients with type 2 diabetes with exenatide once weekly versus oral glucose-lowering medications or insulin glargine: achievement of glycemic and cardiovascular goals

(2013) Alison R Meloni et al.   Cardiovascular Diabetology

Effects of correction of vitamin D insufficiency on serum osteocalcin and glucose metabolism in obese children

(2013) Preamrudee Poomthavorn et al.   CLINICAL ENDOCRINOLOGY

Diabetes and bone health

(2013) Marianna Antonopoulou et al.   MATURITAS

Biomarkers for Osteoporosis Management

(2012) Patrick Garnero   Molecular Diagnosis & Therapy

Serum levels of bone resorption markers are decreased in patients with type 2 diabetes

(2011) Rebeca Reyes-García et al.   ACTA DIABETOLOGICA

A five-year prospective study of bone mineral density in men and women with diabetes: The Fremantle Diabetes Study

(2011) Emma J. Hamilton et al.   ACTA DIABETOLOGICA

Regulation of glucose metabolism and the skeleton

(2011) Kong Wah Ng   CLINICAL ENDOCRINOLOGY

Efficacy and Safety of Exenatide Once Weekly Versus Metformin, Pioglitazone, and Sitagliptin Used as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4): A 26-week double-blind study

(2011) D. Russell-Jones et al.   DIABETES CARE

Glucagon Like Peptide-1 Receptor Expression in the Human Thyroid Gland

(2011) Belinda Gier et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Incretin Receptors in Non-Neoplastic and Neoplastic Thyroid C Cells in Rodents and Humans: Relevance for Incretin-Based Diabetes Therapy

(2011) Beatrice Waser et al.   NEUROENDOCRINOLOGY

Diabetes and fractures: an overshadowed association

(2011) Natasha B Khazai et al.   Current Opinion in Endocrinology Diabetes and Obesity

Effects of vildagliptin on postprandial markers of bone resorption and calcium homeostasis in recently diagnosed, well-controlled type 2 diabetes patients*

(2011) Mathijs C. BUNCK et al.   Journal of Diabetes

Bone and glucose metabolism: A two-way street

(2010) Katherine J. Motyl et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Insulin Signaling in Osteoblasts Integrates Bone Remodeling and Energy Metabolism

(2010) Mathieu Ferron et al.   CELL

Exenatide treatment did not affect bone mineral density despite body weight reduction in patients with type 2 diabetes

(2010) M. C. Bunck et al.   DIABETES OBESITY & METABOLISM

Presence of a functional receptor for GLP-1 in osteoblastic cells, independent of the cAMP-linked GLP-1 receptor

(2010) Bernardo Nuche-Berenguer et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus

(2010) I. Kanazawa et al.   OSTEOPOROSIS INTERNATIONAL

Bone Loss in Diabetes: Use of Antidiabetic Thiazolidinediones and Secondary Osteoporosis

(2010) Beata Lecka-Czernik   Current Osteoporosis Reports

Thiazolidinediones and Fractures in Men and Women

(2009) Colin R. Dormuth et al.   ARCHIVES OF INTERNAL MEDICINE

Effect of GLP-1 Treatment on Bone Turnover in Normal, Type 2 Diabetic, and Insulin-Resistant States

(2009) Bernardo Nuche-Berenguer et al.   CALCIFIED TISSUE INTERNATIONAL

One-Year Treatment With Exenatide Improves  -Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients: A randomized, controlled trial

(2009) M. C. Bunck et al.   DIABETES CARE

Adiponectin Is Associated with Changes in Bone Markers during Glycemic Control in Type 2 Diabetes Mellitus

(2009) Ippei Kanazawa et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states

(2009) Bernardo Nuche-Berenguer et al.   REGULATORY PEPTIDES

Use of Thiazolidinediones and Fracture Risk

(2008) Christian Meier et al.   ARCHIVES OF INTERNAL MEDICINE

Relationship between osteocalcin and glucose metabolism in postmenopausal women

(2008) Jee-Aee Im et al.   CLINICA CHIMICA ACTA

Plasma Osteocalcin Is Inversely Related to Fat Mass and Plasma Glucose in Elderly Swedish Men

(2008) Jenny M Kindblom et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Serum Osteocalcin Level Is Associated with Glucose Metabolism and Atherosclerosis Parameters in Type 2 Diabetes Mellitus

(2008) Ippei Kanazawa et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Changes in Bone Mineral Density, Body Composition and Adiponectin Levels in Morbidly Obese Patients after Bariatric Surgery

(2008) Fernando Carrasco et al.   OBESITY SURGERY

The Murine Glucagon-Like Peptide-1 Receptor Is Essential for Control of Bone Resorption

(2007) Chizumi Yamada et al.   ENDOCRINOLOGY